Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appoint of Certain Officers; Compensatory Arrangements of Certain Officers.

Departure of Chief Financial Officer

On October 16, 2025, Renae Cormier resigned from her position as Chief Financial Officer (and as principal financial officer and principal accounting officer) of Semler Scientific, Inc., or Semler Scientific, effective October 30, 2025, to pursue another opportunity.

Appointment of Interim Chief Financial Officer and Principal Financial Officer

In light of Ms. Cormier's resignation, the board of directors of Semler Scientific appointed Dr. Douglas Murphy-Chutorian, President and Chief Executive Officer (principal executive officer), to serve as Semler Scientific's interim Chief Financial Officer and principal financial officer and principal accounting officer, in addition to his current duties effective from October 30, 2025.

Biographical information for Dr. Murphy-Chutorian is set forth in Semler Scientific's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on July 17, 2025 and is incorporated herein by reference. Dr. Murphy-Chutorian will not receive any additional compensation in connection with this interim appointment.